Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line

Only 39 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources WALTHAM, Mass., April 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceut...

Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder

Owing to Safety, Escitalopram Will Remain as the Clinical Gold Standard Treatment, According to a New Report from Decision Resources WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare...

Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Maryland's Emerging Company of the Year Award

ROCKVILLE, Md., May 19 /PRNewswire-USNewswire/ -- On Thursday May 15, 2008 Sanaria Inc. was named Emerging Company of the Year at the annual Technology Council of Maryland's Tech Awards Celebration honoring the state's technology leaders and organizations. http://techcouncilmd.com/News/tcmn...

Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis

Although Some Emerging Therapies Hold Promise, Enbrel Will Remain the Clinical Gold Standard Through 2016, According to a New Report from Decision Resources WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and adv...

FDA Announces Audio Broadcasts on Emerging Drug Safety Information

ROCKVILLE, Md., April 20,2007-The U.S. Food and Drug Administration (FDA) is alerting health care professionals and consumers to the availability of audio broadcasts that provide emerging drug safety information. The broadcasts, commonly known as podcasts, can be transmitted to personal computers ...

Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jul 9, 2007 - Icagen, Inc. (NASDAQ: ICGN) today announced that P. Kay Wagoner, Ph.D., Chief Executive Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference in New York City on Thursday, July 12th at 2:00 p.m. ET. ...

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

NEW YORK--(BUSINESS WIRE)--Jul 6, 2007 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007 at 2:30 p.m. ET at the Mandarin Oriental H...

SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

DUBLIN, Calif., July 06, 2007 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that Dr. Gregory Berk, Chief Medical Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007 at the Mandarin Oriental Hotel in New York City. Sup...

GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Jul 5, 2007 - GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that Geoffrey Cox, Ph.D., GTC's Chairman and CEO, is scheduled to present on Wednesday, July 11, 2007 at 9:00 a.m. during the C.E. Unterberg, Towbin Emerging Growth Life Opportunities C...

Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Metabasis Therapeutics (NASDAQ:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by targeting the liver and liver pathways, announced today that Jo...

Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Accelrys, Inc. (NASDAQ:ACCL), the leading provider of scientific business intelligence software and services, announced today that its CFO, Rick Russo, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference in New York on July 1...

ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the C.E. Unterberg, Towbin Emerging Growth Opportunities Confe...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...le activities. Approximately 8% of adults will experience major depression at some time in their lives. About Labopharm Inc. Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead produc...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...on studies with ProLindac in specific tumor types at their expense based on these results. About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' produc...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

... on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual prope...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...tiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introduct...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

...ern PA to help them grow and succeed. Innovation Works is one of the most active seed-stage investors in the country, having invested in more than 120 emerging technology companies since beginning their seed fund in 1999. Those companies have gone on to raise over $600 million in additional capital from a di...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

...ng 50 states and 124 nations, the UA is on the forefront of discoveries -- from the depths of space to the medical and genetic mysteries of life, from emerging trends in climate change to the broad complexities of the human condition. For more information, visit www.arizona.edu About Arizona Alz...

Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class

...es the significance of the work. "Charcot-Marie-Tooth (CMT) is one of the most common inherited neurological disorders, with typical symptoms usually emerging in early adulthood, including loss of muscle mass, pain and sensitivity, foot deformations and difficulties in walking. Human genome sequencing revea...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

...ed with reduced cognitive function. However, no study has yet investigated if PTSD increases the risk of developing dementia. To address this emerging issue, Kristine Yaffe, MD, Professor of Psychiatry, Neurology and Epidemiology and Associate Chair of Research for the Department of Psychiatry at the...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

... Access is actively seeking co-development partners for all applications of Thiarabine. About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' produc...

Relievant Medsystems Announces Completion of $20 Million Financing

...genthaler Ventures Morgenthaler Ventures is one of the country's premier venture capital firms with a track record of partnering with more than 300 emerging companies over forty years. With offices in Menlo Park, Boston and Boulder, the firm manages over $3 billion in capital and invests in early stage li...

Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia

...idate as we progress partnership discussions in parallel. ' Notes to Editors: About Vantia Therapeutics Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets. Formed in 2008 as a spin-out of Ferring Re...

More Gene Mutations Linked to Autism Risk

...New Genetic Mutations Acting Together-- PHILADELPHIA, June 26 /PRNewswire-USNewswire/ -- More pieces in the complex autism inheritance puzzle are emerging in the latest study from a research team including geneticists from The Children's Hospital of Philadelphia, the University of Pennsylvania School o...

ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases

...is time." ALP Life Sciences, LLC is a life sciences research and development company focused on therapeutics and diagnostics based on the new and emerging science of Applied Lipid Polymorphism . ALP Life Sciences, LLC is currently evaluating strategic relationships in the area of principal investigators...

Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies

...ling and identification. Covance's clinical development services include Phase I-IV clinical trial support in more than 55 countries, including emerging markets across Asia Pacific, Central and Eastern Europe, and Latin America. About Covance Covance, with headquarters in Princeton, New Jerse...

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

...yopreserved. About Cordex Pharma, Inc. Cordex is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduc...

Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients

...amin D repletion should be considered for all people with cancer. (Logo: http://www.newscom.com/cgi-bin/prnh/20090612/CTCALOGO ) "While emerging evidence suggests the protective role of vitamin D in cancer, vitamin D status is not routinely assessed in cancer patients despite the high prevalenc...

Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial

...PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, announced today that i...and clinically effective regenerative healing products that can satisfy the emerging needs of surgeons and the patient communities they serve." About Dur...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

...s Specialty Pharmacy, the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy -- a key element in reforming America's he...

Boehringer Ingelheim Unveils Diabetes Pipeline

...the U.S.(3) Boehringer Ingelheim is also investigating sodium-dependent glucose co-transporter-2 inhibitors (SGLT-2 inhibitors), which are a new, emerging class of antidiabetic compounds that block tubular reabsorption of glucose in the kidney.(4) Phase IIb clinical trials for this innovative approach to...

Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

... shown to have much better solid tumor efficacy than cytarabine in preclinical models. About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' produc...

Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry

...ior author and vice president of clinical research, Dainippon Sumitomo Pharma America, Inc. "Findings from this phase 2 study are consistent with data emerging from the lurasidone global development program, including a recently completed, large phase 3 placebo-controlled trial." The primary efficacy me...

Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)

...ows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance. About Advanced Life Sciences Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and comm...

CuraGen Updates CR011-vcMMAE Data at ASCO

...presenting additional data on the Phase II study in the second half of the year," commented Dr. Ronit Simantov, Chief Medical Officer of CuraGen. "The emerging role of GPNMB, which is present in 25-40% of breast cancer patients, combined with our clinical activity, suggests that GPNMB may be an important new ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

...s Specialty Pharmacy, the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy -a key element in reforming America's heal...

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

...tiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introduct...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

...ssion of Hepatitis-C Virus (HCV) and Human Immunodeficiency Virus (HIV), and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds promise in cancer care, as research studies verify the Hemopurifier(R) effectively captures immunosu...

CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients

...is extremely to very important to prevent infections to achieve successful outcomes in chemotherapy patients. Physicians are also concerned about emerging antibiotic resistance in this population, with 96 percent of ID specialists and 79 percent of oncologists reporting an increase in antibiotic-resistan...

Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections

...e, primary research and extensive understanding of emerging therapies and forecasts. These reports examine the...antibiotic prescribing patterns and receptivity to emerging antibiotics. Members of the media are welcome...s Insight Series: Analyzing Prescribing Trends and emerging Therapies in the Hospital Antibiotic Market. The...